Afsana Sheikh

2.6k total citations · 3 hit papers
44 papers, 1.9k citations indexed

About

Afsana Sheikh is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Afsana Sheikh has authored 44 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 15 papers in Biomaterials and 9 papers in Biomedical Engineering. Recurrent topics in Afsana Sheikh's work include RNA Interference and Gene Delivery (19 papers), Nanoparticle-Based Drug Delivery (13 papers) and Advanced biosensing and bioanalysis techniques (9 papers). Afsana Sheikh is often cited by papers focused on RNA Interference and Gene Delivery (19 papers), Nanoparticle-Based Drug Delivery (13 papers) and Advanced biosensing and bioanalysis techniques (9 papers). Afsana Sheikh collaborates with scholars based in India, Saudi Arabia and Iran. Afsana Sheikh's co-authors include Prashant Kesharwani, Mohammed A. S. Abourehab, Shadab Md, Mahak Fatima, Virendra Gajbhiye, Rajesh Salve, Amirhossein Sahebkar, Nazeer Hasan, Neelima Gupta and Waleed Y. Rizg and has published in prestigious journals such as Journal of Controlled Release, International Journal of Pharmaceutics and Molecular Cancer.

In The Last Decade

Afsana Sheikh

43 papers receiving 1.8k citations

Hit Papers

Gold nanoparticles and gold nanorods in the landscape of ... 2023 2026 2024 2025 2023 2023 2023 50 100 150 200

Peers

Afsana Sheikh
Afsana Sheikh
Citations per year, relative to Afsana Sheikh Afsana Sheikh (= 1×) peers Aniruddha Roy

Countries citing papers authored by Afsana Sheikh

Since Specialization
Citations

This map shows the geographic impact of Afsana Sheikh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afsana Sheikh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afsana Sheikh more than expected).

Fields of papers citing papers by Afsana Sheikh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afsana Sheikh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afsana Sheikh. The network helps show where Afsana Sheikh may publish in the future.

Co-authorship network of co-authors of Afsana Sheikh

This figure shows the co-authorship network connecting the top 25 collaborators of Afsana Sheikh. A scholar is included among the top collaborators of Afsana Sheikh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afsana Sheikh. Afsana Sheikh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qureshi, Saima, Muzammil Hussain, Afsana Sheikh, et al.. (2024). A recent insight of applications of gold nanoparticles in glioblastoma multiforme therapy. International Journal of Pharmaceutics. 660. 124301–124301. 18 indexed citations
2.
Hasan, Nazeer, Mohammad Imran, Kashif Haider, et al.. (2023). Formulation and development of novel lipid-based combinatorial advanced nanoformulation for effective treatment of non-melanoma skin cancer. International Journal of Pharmaceutics. 632. 122580–122580. 47 indexed citations
3.
Sheikh, Afsana, et al.. (2023). A review of various analytical methods for the estimation of olanzapine: An antipsychotic drug. Biomedical Chromatography. 37(7). e5632–e5632.
4.
Sheikh, Afsana, et al.. (2023). Self-assembled Gallic acid loaded lecithin-chitosan hybrid nanostructured gel as a potential tool against imiquimod-induced psoriasis. Environmental Research. 234. 116562–116562. 12 indexed citations
5.
Hasan, Nazeer, Mohammad Imran, Afsana Sheikh, et al.. (2023). Advanced multifunctional nano-lipid carrier loaded gel for targeted delivery of 5-flurouracil and cannabidiol against non-melanoma skin cancer. Environmental Research. 233. 116454–116454. 39 indexed citations
6.
Khan, Mohammad Sameer, Afsana Sheikh, Mohammed A. S. Abourehab, Neelima Gupta, & Prashant Kesharwani. (2023). Understanding the theranostic potential of quantum dots in cancer management. Materials Today Communications. 36. 106424–106424. 37 indexed citations
7.
Sheikh, Afsana, Nagashekhara Molugulu, Saad Ali Alshehri, et al.. (2023). Hyaluronic acid engineered gallic acid embedded chitosan nanoparticle as an effective delivery system for treatment of psoriasis. Environmental Research. 238(Pt 1). 117086–117086. 17 indexed citations
8.
Sheikh, Afsana, et al.. (2023). Drug permeation enhancement, efficacy, and safety assessment of azelaic acid loaded SNEDDS hydrogel to overcome the treatment barriers of atopic dermatitis. Environmental Research. 236(Pt 2). 116850–116850. 22 indexed citations
9.
Fatima, Mahak, Afsana Sheikh, Waleed Hassan Almalki, et al.. (2023). Recent advancement on albumin nanoparticles in treating lung carcinoma. Journal of drug targeting. 31(5). 486–499. 26 indexed citations
10.
Sheikh, Afsana, Shadab Md, Rajesh Salve, et al.. (2023). GLUT1 transporter-facilitated solid lipid nanoparticles loaded with anti-cancer therapeutics for ovarian cancer targeting. International Journal of Pharmaceutics. 637. 122894–122894. 27 indexed citations
11.
Abbaspour, Mohammadreza, et al.. (2023). Nano-curcumin formulations for targeted therapy of colorectal cancer. Journal of Drug Delivery Science and Technology. 88. 104943–104943. 12 indexed citations
12.
Sheikh, Afsana, Mohammed A. S. Abourehab, Alaa S. Tulbah, & Prashant Kesharwani. (2023). Aptamer-grafted, cell membrane-coated dendrimer loaded with doxorubicin as a targeted nanosystem against epithelial cellular adhesion molecule (EpCAM) for triple negative breast cancer therapy. Journal of Drug Delivery Science and Technology. 86. 104745–104745. 29 indexed citations
13.
Sheikh, Afsana, et al.. (2022). Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy. Journal of Biomaterials Science Polymer Edition. 34(3). 398–418. 35 indexed citations
14.
Fatima, Mahak, Afsana Sheikh, Mohammed A. S. Abourehab, & Prashant Kesharwani. (2022). Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer. Pharmaceutics. 14(11). 2432–2432. 26 indexed citations
15.
Singh, Vanshikha, Afsana Sheikh, Mohammed A. S. Abourehab, & Prashant Kesharwani. (2022). Dostarlimab as a Miracle Drug: Rising Hope against Cancer Treatment. Biosensors. 12(8). 617–617. 37 indexed citations
16.
Alhalmi, Abdulsalam, Wasi Khan, Afsana Sheikh, et al.. (2022). Folic acid engineered sulforaphane loaded microbeads for targeting breast cancer. Journal of Biomaterials Science Polymer Edition. 34(5). 674–694. 17 indexed citations
17.
Sheikh, Afsana, et al.. (2022). Amelioration of Full-Thickness Wound Using Hesperidin Loaded Dendrimer-Based Hydrogel Bandages. Biosensors. 12(7). 462–462. 38 indexed citations
18.
Kesharwani, Prashant, Mahak Fatima, Vanshikha Singh, et al.. (2022). Itraconazole and Difluorinated-Curcumin Containing Chitosan Nanoparticle Loaded Hydrogel for Amelioration of Onychomycosis. Biomimetics. 7(4). 206–206. 29 indexed citations
19.
Sheikh, Afsana & Prashant Kesharwani. (2021). An insight into aptamer engineered dendrimer for cancer therapy. European Polymer Journal. 159. 110746–110746. 54 indexed citations
20.
Kesharwani, Prashant, et al.. (2021). Formulation development and in vitro–in vivo assessment of protransfersomal gel of anti-resorptive drug in osteoporosis treatment. International Journal of Pharmaceutics. 608. 121060–121060. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026